LaminarForge
501(c)(3) nonprofit in formationOpen-source platformHSV-2 research infrastructure

LaminarForge

Open nonprofit infrastructure for HSV-2 therapeutics research: cell culture, tissue-on-chip systems, AAV selectivity screening, imaging, lab automation, and public validation records.

Current plan

LaminarForge is not open-sourcing a finished device. It is open-sourcing the buildout of a research platform.

The exact hardware and biological workflows will evolve as testing teaches what works. The operating model is fixed: nonprofit, open-source, transparent, validation-first, and milestone-driven.

What needs to be done

Build the pieces that make later experiments inspectable.

The near-term work is infrastructure, not a final therapeutic claim. Funding should attach to concrete inputs: legal formation, prototype parts, validation fixtures, consumables, lab access, imaging, automation, and public documentation.

Nonprofit formation

Legal setup, donation rails, governance notes, and public grant language so funding can be tied to specific work.

16-slot cassette

A reusable 4 x 4 carrier direction for one AAV capsid, promoter, payload, dose, or other defined condition.

Disposable fluid path

Tubing, seals, witness marks, condition labels, and handling assumptions that can be replaced between runs.

No-cell validation

Fit, leak behavior, bubble control, flow balance, imaging access, environmental logs, and run records before biology.

Cell-culture readiness

Sterile workflow, sensory-neuron and tissue-on-chip planning, consumables, and outside lab or core-facility support.

Automation and data

Liquid handling, imaging, barcode or condition identity, and public data packages for reproducible comparisons.

Open by default

Funding should make the public record stronger.

Every funded block should leave behind something useful: a BOM, a drawing, a decision log, a test result, a failure report, or a reproducible workflow note.

  • Publish CAD, firmware, software, BOMs, decision logs, and validation results when they are mature enough to inspect.
  • Treat failed designs as part of the record, not as private cleanup work hidden behind a polished release.
  • Use funding targets that map to concrete materials, equipment, tests, and public milestones.
  • Keep sensitive biological claims conservative: this is nonclinical research infrastructure, not a cure claim, treatment, or diagnostic product.

Current reference build

Start with the 16-slot cassette, but keep the design honest.

This is the first physical format to validate, not a promise that every downstream design decision is settled. Scale comes from parallel cassettes or sealed modules under matched environmental controls.

Fixed first format

The first physical cassette build is a 16-slot, 4 x 4 cassette.

Isolation rule

One cassette means one AAV condition. Candidate mixing waits until isolation and carryover have been validated.

Immediate hardware

Reusable carrier, lid and clamp, gasket or witness system, barcode or condition ID, and dock/module interfaces.

Validation order

No-cell and media-only checks come before interpreting any biological readout.

Funding roadmap

Transparent, BOM-style targets before broad fundraising.

These are planning ranges, not final vendor quotes. As each design freezes, the ranges should be replaced by public line-item BOMs with vendors, quantities, alternates, and status.

BlockInputsEstimateUnlocks
Formation and public infrastructureNonprofit setup, donation processing, governance docs, public repository structure, and grant materials.$1k-$5kA legal and public surface that can accept support and show exactly where it goes.
Mechanical cassette prototypeReusable carrier, lid/clamp, gaskets, labels, fixtures, fabrication iterations, and inspection supplies.$2k-$8kA physical 16-slot cassette that can be handled, sealed, labeled, and revised in public.
No-cell validation packageTubing harnesses, pumps or pressure-control assumptions, dyes, leak tests, flow checks, imaging access, and run logs.$2k-$10kEvidence that the platform behaves physically before cells are added.
Cell-culture readinessSterile workflow capability, consumables, incubation assumptions, cell-model planning, and lab or core-facility support.$15k-$60kA path from mechanical validation into responsible biological model work.
AAV screening readinessMatched environmental controls, condition isolation checks, imaging/readout pipeline, dose recovery, and reproducibility records.$25k-$100kParallel cassette comparisons without pretending the first platform is already final.

Contact

Support the buildout

For funding, grant, lab, fabrication, review, or collaboration questions, use the project inbox.

admin@laminarforge.org